menu
    • menu

    Company profile for Piramal Pharma Solutions

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-30

    Virtual Booth

    Contact Supplier

    granules-india-limited-m-2025-07-07

    Virtual Booth

    Contact Supplier

    Allsino Pharma excels in R&D & manufacturing of RSMs, GMP intermediates, & APIs; ISO-certified, GMP-compliant, accredited by NMPA.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    SERVICES

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Piramal Pharma Solutions (PPS) is a CDMO that provides end-to-end solutions for drug development and manufacturing across the drug life cycle to its clients in North America, Europe and Asia through a globally integrated network of facilities. It offers a range of services from drug discovery to commercial supply of APIs and finished dosage forms, along with specialized services like HPAPIs, antibody drug conjugations, sterile...
    Piramal Pharma Solutions (PPS) is a CDMO that provides end-to-end solutions for drug development and manufacturing across the drug life cycle to its clients in North America, Europe and Asia through a globally integrated network of facilities. It offers a range of services from drug discovery to commercial supply of APIs and finished dosage forms, along with specialized services like HPAPIs, antibody drug conjugations, sterile fill/finish, peptide products and services and potent solid oral drug products. PPS also provides services for biologics, including vaccines, gene therapies and monoclonal antibodies through its subsidiary Yapan Bio.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Piramal Pharma SolutionsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    18655 Krause St, Riverview, MI 48193
    Telephone
    Telephone
    +1 734 282 3370
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.piramalpharmasolutions.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/piramal-pharma-solutions/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/PiramalPharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CPhI South East Asia

    Not Confirmed

    envelop Contact Supplier

    CPhI South East Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    Alchem NicSelect™ grants customers royalty-free access to T-MAX™ tech for 3-in-1 vape satisfaction in flavour-restricted markets

    micAlchem NicSelect™ grants customers royalty-free access to T-MAX™ tech for 3-in-1 vape satisfaction in flavour-restricted markets

    With increasing flavour bans in key markets, vaping brands are facing significant challenges in providing satisfying alternatives to vapers and smokers looking to transition. Recognising this need, Alchem NicSelect™ is making a bold move by offering its key customers royalty-free and unrestricted geographical access to its revolutionary T-MAX™ technology.“At Alchem NicSelect™, we understand the urgency for vaping brands to adapt to new regulations without compromising on satisfaction. By offering royalty-free access to T-MAX™ technology, we empower our customers to provide the closest cigarette-like experience possible, even in markets with strict flavour restrictions,” said Riccardo Santambrogio, Europe Sales Manager.HIGHLIGHTS// offering royalty-free access to T-MAX™ technology/ unrestricted geographical access/ closest cigarette-like experience Addressing the biggest barrier: Nicotine satisfactionOne of the primary reasons many vapers are dissatisfied and smokers struggle to switch to vaping is that traditional nicotine solutions fail to replicate the rapid satisfaction provided by cigarettes. Nicotine replacement therapies (NRTs) and even conventional vaping products often lack the immediate nicotine hit, throat feel, and overall experience that smokers are accustomed to. T-MAX™ solves this problem by engineering a nicotine experience that closely mimics cigarette consumption without relying on flavours.T-MAX™ provides a unique 3-in-1 approach:1. The Speed of a Cigarette – Rapid nicotine delivery and rush within seconds for immediate satisfaction.2. The Power of Nicotine Salts – A stronger perceived nicotine effect without exceeding legal limits (20 mg/ml nicotine limit under the European Tobacco Products Directive). With T-MAX™, 8 mg/ml feels like 20 mg/ml, and 14 mg/ml feels like 40 mg/ml.3. The Throat Hit of Freebase Nicotine – Especially in a flavour-free formulation, the combined ingredients in T-MAX™ deliver an even more satisfying throat feel than expected from nicotine base, much closer to and more familiar with a cigarette throat feel that habitual smokers recognise.HIGHLIGHTS// unique 3-in-1 approach/ rush within seconds/ stronger perceived nicotine effect without exceeding legal limits/ more satisfying throat feel that habitual smokers recogniseNo flavour, but not less satisfyingWhile flavours have traditionally played a role in vaping adoption, market realities are shifting. With flavour bans spreading across regions, brands need solutions that deliver satisfaction without relying on taste. Consumer research has shown that T-MAX™ performs exceptionally well even without added flavours. Since most cigarette smokers do not smoke for the tobacco flavour but rather for the nicotine hit and habitual experience, T-MAX™ provides a viable alternative that aligns with new regulatory landscapes.HIGHLIGHTS// flavour bans spreading across regions/ T-MAX™ performs exceptionally well even without added flavoursEmpowering vape brands with free access to T-MAX™By granting customers royalty-free access to the T-MAX™ technology, Alchem NicSelect™ is removing barriers for vaping brands and original equipment manufacturers (OEMs) looking to adapt to regulatory changes. This open-access approach ensures that manufacturers can integrate T-MAX™ into their product lines without additional costs, allowing them to offer superior nicotine satisfaction in markets where flavours are no longer an option.HIGHLIGHTS// removing barriers for vaping brands and OEMs looking to adapt/ manufacturers can integrate T-MAX™ into product lines without additional costsThe future of vaping in restricted marketsWith T-MAX™, the vaping industry has a powerful tool to retain customers and convert smokers who have struggled with traditional vaping products. By delivering the key elements of cigarette satisfaction — without combustion or flavours — T-MAX™ is set to redefine what a satisfying vape experience means in a post-flavour-ban world.“Our commitment to innovation and accessibility means we are providing our customers with the solutions they need to navigate an evolving regulatory landscape. T-MAX™ allows brands to offer a highly satisfying experience that mimics smoking without relying on flavours. The message is clear: no flavour, but not less satisfying”, added Santambrogio.HIGHLIGHTS// powerful tool to retain customers and convert smokers/ delivering the key elements of cigarette satisfaction without combustion or flavours/ no flavour, but not less satisfying

    Impressions: 1275

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets

    Radio Compass
    06 May 2025
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    ReelPharmaProviding RSMs & API to Global Pharma CompaniesProviding RSMs & API to Global Pharma Companies

    Providing RSMs & API to Global Pharma Companies
    Providing RSMs & API to Global Pharma Companies

    reelProviding RSMs & API to Global Pharma Companies

    This PharmaReel showcases Allsino Pharmaceutical, a company that provides GMP-certified RSMs and APIs to global pharma companies, specializing in peptides, oligonucleotides, and small molecule CDMO services. Allsino has a presence in the US, EU, China and Japan.

    Impressions: 1684

    read-more

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    J&J’s Intra‑Cellular buyout, BMS’ oncology gambit, Sanofi’s Blueprint acquisition drive mega deals in H1 2025

    J&J’s Intra‑Cellular buyout, BMS’ oncology gambit, Sanofi’s Blueprint acquisition drive mega deals in H1 2025

    The pharmaceutical industry has witnessed a wave of mergers, acquisitions, and strategic partnerships so far in the first half (H1) of 2025, with deal values exceeding US$ 170 billion.PharmaCompass’ data shows oncology alone accounted for nearly US$ 47 billion in deal value, followed by US$ 18 billion each in immunology and psychiatry, US$ 17 billion in nutrition/weight loss and US$ 7 billion in neurology.Pharma majors such as Johnson & Johnson and Bristol Myers Squibb led with two deals worth over US$ 10 billion each. Sanofi executed a series of deals in the immunology and neuro-inflammation space. And Eli Lilly stood out for its aggressive dealmaking, which spanned oncology, pain, RNA therapies, and AI-driven oligonucleotides. In all, it signed seven deals worth over US$ 1 billion each. View Pharma & Biotech Acquisitions, Deals & Agreements in 2025 as of June 14 (Free Excel Available)H1 records several mega deals as J&J buys Intra-Cellular, BMS ties up with BioNTech, Sanofi acquires BlueprintJohnson & Johnson dominated headlines with its US$ 14.6 billion acquisition of Intra-Cellular Therapies in January 2025. This marks the largest biopharma deal since Novo Nordisk’s US$ 16.5 billion acquisition of Catalent in February 2024. This acquisition positions J&J as a formidable player in the neuroscience space. Bristol Myers Squibb entered into a US$ 11.1 billion partnership with BioNTech. The deal structure — US$ 3.5 billion in unconditional payments and up to US$ 7.6 billion in milestone payments — demonstrates BMS’ confidence in BNT327, a next-generation bispecific antibody in phase 3 trials for treating extensive stage small cell lung cancer and non-small cell lung cancer.Sanofi acquired Blueprint Medicines for US$ 9.5 billion in order to enhance its rare disease portfolio. The French drugmaker is also creating a comprehensive immunology portfolio. The company signed a US$ 1.9 billion deal for Dren Bio’s DR-0201 bispecific antibody for autoimmune diseases. Sanofi also acquired Vigil Neuroscience for US$ 470 million for its phase 2-ready Alzheimer’s disease candidate. Additionally, the drugmaker secured a US$ 1.84 billion global license agreement with Earendil Labs for two next-generation bispecific antibodies.Pfizer’s US$ 6.05 billion partnership with 3SBio provides it global licensing rights (excluding China) for SSGJ-707, a bispecific antibody currently undergoing multiple clinical trials in China for non-small cell lung cancer, metastatic colorectal cancer, and gynecological tumors. View Pharma & Biotech Acquisitions, Deals & Agreements in 2025 as of June 14 (Free Excel Available) Obesity gold rush sees Roche, AbbVie, Sciwind ink deals; Novo pledges over US$ 5 bn across three dealsThe obesity therapeutics market has triggered intense competition among pharmaceutical giants. Roche’s US$ 5.3 billion partnership with Zealand Pharma is focused on petrelintide, an amylin analog designed to preserve lean mass better than existing GLP-1-based treatments. The collaboration combines petrelintide with Roche’s dual GLP-1/GIP receptor agonist CT-388, creating a differentiated obesity treatment.Market leader Novo Nordisk has promised over US$ 5 billion across three major obesity deals in 2025. The US$ 2.2 billion Septerna collaboration targets oral small molecule medicines for obesity and cardiometabolic diseases.Novo signed a separate US$ 2 billion agreement with China’s United Biotechnology for UBT251, a triple agonist for GLP-1, GIP, and glucagon receptors in phase 2 clinical development for obesity, type 2 diabetes, and other diseases. The company’s third major deal, a US$ 1 billion partnership with Lexicon Pharmaceuticals, provides it access to LX9851, a molecule in preclinical development for obesity and associated metabolic disorders.Sciwind Biosciences secured a US$ 2.5 billion global licensing and collaboration agreement with Verdiva Bio Limited for the global development and commercialization of a portfolio of metabolic diseases therapies. AbbVie entered the amylin arena through its US$ 2.2 billion Gubra partnership for GUB014295, a candidate in phase 1 trials for treating obesity. View Pharma & Biotech Acquisitions, Deals & Agreements in 2025 as of June 14 (Free Excel Available) Molecular glue degraders draw investments; Lilly signs seven deals over US$ 1 billion eachMolecular glue degraders have emerged as a transformative therapeutic modality, attracting significant investment across multiple partnerships. AbbVie’s US$ 1.64 billion collaboration with Neomorph leverages the biotech’s leading molecular glue discovery platform for oncology and immunology applications.Genentech’s potential US$ 2.1 billion partnership with Orionis Biosciences focuses on small-molecule monovalent glue medicines for novel and challenging oncology targets. This is the second partnership between the two companies, following their initial 2023 collaboration.Eli Lilly has collaborated with Magnet Biomedicine, utilizing Magnet’s TrueGlue discovery platform for oncology applications. The deal could be worth up to US$ 1.3 billion.Eli Lilly has emerged as one of 2025’s most active dealmakers, with approximately seven deals exceeding US$ 1 billion each. The company’s US$ 2.5 billion Scorpion Therapeutics acquisition provides access to STX-478, an experimental oral therapy in early-stage trials for breast cancer and advanced solid tumors, potentially addressing 30 to 40 percent of hormone-positive breast cancer patients.On June 17, Lilly announced the acquisition of gene-editing startup Verve Therapeutics for US$ 1.3 billion. Lilly’s US$ 1 billion SiteOne acquisition announced in May brings STC-004, a phase 2-ready non-opioid chronic pain treatment to its pipeline. Other partnerships announced by Lilly include a US$ 1.4 billion capsid licensing deal with Sangamo for central nervous system disease genomic medicines and a US$ 1.3 billion collaboration with South Korean company Rznomics for RNA-based hearing loss treatments. Lilly has also strengthened its oligonucleotide pipeline through a potential US$ 1 billion collaboration with Creyon Bio for AI-designed oligonucleotide therapies targeting RNA. View Pharma & Biotech Acquisitions, Deals & Agreements in 2025 as of June 14 (Free Excel Available) Merck KGaA acquires SpringWorks for US$ 3.9 bn; Novartis buys out Anthos for US$ 3.1 bnAstraZeneca signed a US$ 5.3 billion AI-led research agreement with China’s CSPC Pharmaceuticals Group to advance the discovery of novel oral candidates for immunological diseases. Merck KGaA acquired SpringWorks for US$ 3.9 billion in April, which gave it access to two FDA-approved therapies — Ogsiveo (nirogacestat), the first and only approved therapy for adult patients with progressing desmoid tumors requiring systemic treatment, and Gomekli (mirdametinib), the first and only FDA-approved therapy for adults and children with neurofibromatosis type 1-associated plexiform neurofibromas.Novartis’ US$ 3.1 billion Anthos Therapeutics acquisition centered around abelacimab, a potential first-in-class monoclonal antibody currently in three phase 3 studies for stroke and systemic embolism prevention in atrial fibrillation patients.GSK’s US$ 2 billion acquisition of Boston Pharmaceuticals’ efimosfermin targets steatotic liver disease (fatty liver disease). The medicine is also in clinical development for MASH treatment. GSK’s second major deal involved the US$ 1.15 billion acquisition of US biotech IDRx, strengthening its gastrointestinal cancer portfolio.The pharma industry also drew some private equity interest as Bain Capital acquired Japan’s Mitsubishi Tanabe Pharma from Mitsubishi Chemical Group for US$ 3.3 billion. View Pharma & Biotech Acquisitions, Deals & Agreements in 2025 as of June 14 (Free Excel Available) Our viewDespite an uncertain geopolitical environment, the year has seen a surge in M&As and dealmaking in the first half of 2025. However, a sizable chunk of the acquisitions were bolt-on transactions, indicating that companies are not ready to take on risks, and are buying out smaller players who strategically fit into their operations. Going forward, there are indications that M&A activity will stay strong throughout 2025. 
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 6643

    https://www.pharmacompass.com/radio-compass-blog/j-j-s-intra-cellular-buyout-bms-oncology-gambit-sanofi-s-blueprint-acquisition-drive-mega-deals-in-h1-2025

    #PharmaFlow by PHARMACOMPASS
    19 Jun 2025
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    Carlyle to sell 10% stake in Piramal Pharma
    Carlyle to sell 10% stake in Piramal Pharma

    03 Jul 2025

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/carlyle-sell-up-10-stake-piramal-pharma-moneycontrol-reports-2025-07-03/

    REUTERS
    03 Jul 2025
    Share Share
    Piramal Pharma Solutions Breaks Ground on $90M Expansion Plan
    Piramal Pharma Solutions Breaks Ground on $90M Expansion Plan

    01 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/piramal-pharma-solutions-breaks-ground-on-90m-expansion-plan-302494239.html

    PR NEWSWIRE
    01 Jul 2025
    Share Share
    Piramal Pharma completes USFDA inspection of Aurora facility
    Piramal Pharma completes USFDA inspection of Aurora facility

    02 Jun 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/drug-approval/piramal-pharma-completes-usfda-inspection-of-aurora-facility-with-zero-form-483-observations-17235

    INDPHARMAPOST
    02 Jun 2025
    Share Share
    Piramal Pharma to stay away from prescription business in India
    Piramal Pharma to stay away from prescription business in India

    17 May 2025

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/piramal-pharma-to-stay-away-from-prescription-business-in-india-nandini-piramal/articleshow/121218907.cms

    ECONOMICTIMES
    17 May 2025
    Share Share
    Piramal Pharma reports Rs. 153.50 Cr net profit in Q4 FY25
    Piramal Pharma reports Rs. 153.50 Cr net profit in Q4 FY25

    16 May 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/piramal-pharma-reports-q4-fy25-consolidated-net-profit-of-rs-15350-cr-17160

    INDPHARMAPOST
    16 May 2025
    Share Share
    Piramal Pharma Limited Announces Results for Q4 and FY2025
    Piramal Pharma Limited Announces Results for Q4 and FY2025

    14 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/piramal-pharma-limited-announces-results-for-q4-and-fy2025-302455711.html

    PR NEWSWIRE
    14 May 2025
    Share Share

    ALL APIs

    read-moreClick the button for full data set
    read-moreClick the button for full data set

    01

    Diltiazem Hydrochloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    EPS
    Not Confirmed
    arrow

    Diltiazem Hydrochloride

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    EPS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down Click Us! arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-02-06

    Pay. Date : 2013-01-31

    DMF Number : 14713

    Submission : 2000-01-27

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 1997-121 - Rev 14

    Issue Date : 2022-01-07

    Type : Chemical

    Substance Number : 1004

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 221MF10252

    Registrant's Address : Digwal Village (Sy.Nos.7-70, 70/1 and 70/2), Kohir Mandal, Sangareddy District-502 321, Telangana, India

    Initial Date of Registration : 2009-11-24

    Latest Date of Registration :

    EU-WCInactive-api
    ✖

    Date of Issue : 2022-06-29

    Valid Till : 2025-02-07

    Written Confirmation Number : WC-0123

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 65085-0002

    Start Marketing Date : 2015-05-15

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (50kg/50kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Pampia Co., Ltd.

    Registration Date : 2021-09-24

    Registration Number : 20210310-209-J-866(1)

    Manufacturer Name : Piramal Pharma Limited

    Manufacturer Address : Sy. Nos. 7-70, 70/1 & 70/2 Digwal Village, Kohir Mandal Sangareddy District - 502 321, Telangana, India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Ketoconazole

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    EPS
    Not Confirmed
    arrow

    Ketoconazole

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    EPS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-09-21

    Pay. Date : 2013-09-11

    DMF Number : 17290

    Submission : 2004-04-02

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 1999-049 - Rev 10

    Issue Date : 2022-01-07

    Type : Chemical

    Substance Number : 921

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 303MF10100

    Registrant's Address : Digwal Village (Sy.Nos. 7-70, 70/1 and 70/2), Kohir Mandal, Sangareddy District-502 321, Telangana, India

    Initial Date of Registration : 2021-07-02

    Latest Date of Registration :

    EU-WCInactive-api
    ✖

    Date of Issue : 2022-06-29

    Valid Till : 2025-02-07

    Written Confirmation Number : WC-0123

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 65085-0028

    Start Marketing Date : 1999-03-08

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (25kg/25kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Hyons Co., Ltd.

    Registration Date : 2022-01-10

    Registration Number : 20220110-167-I-630-07

    Manufacturer Name : Piramal Pharma Limited

    Manufacturer Address : Sy. Nos. 7-70, 70/1 and 70/2, Digwal Village, Kohir Mandal, Sangareddy District, Telangana, 502 321, India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Desmopressin Acetate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    EPS
    Not Confirmed
    arrow

    Desmopressin Acetate

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    EPS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2014-01-16

    Pay. Date : 2013-12-06

    DMF Number : 22871

    Submission : 2009-06-16

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2009-087 - Rev 02

    Issue Date : 2022-10-04

    Type : Chemical

    Substance Number : 712

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2023-02-09

    Valid Till : 2026-02-08

    Written Confirmation Number : WC-0549

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 41701-007

    Start Marketing Date : 2011-03-18

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (10g/10g)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Sampoong Finechem Co., Ltd.

    Registration Date : 2022-05-11

    Registration Number : 20210628-209-J-1042(1)

    Manufacturer Name : Piramal Pharma Limited

    Manufacturer Address : Plot No C-43, MIDC, TTC Industrial Area, Turbhe, Off Thane Belapur Road, Navi Mumbai Thane-400703 Maharashtra State, India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Leuprolide Acetate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    EPS
    Not Confirmed
    arrow

    Leuprolide Acetate

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    EPS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 25128

    Submission : 2011-06-30

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2011-274 - Rev 02

    Issue Date : 2024-03-04

    Type : Chemical

    Substance Number : 1442

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2023-02-09

    Valid Till : 2026-02-08

    Written Confirmation Number : WC-0549

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 41701-013

    Start Marketing Date : 2011-03-18

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (135g/135g)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Pharmapia Co., Ltd.

    Registration Date : 2024-06-05

    Registration Number : 20240605-210-J-1603

    Manufacturer Name : Piramal Pharma Limited

    Manufacturer Address : C-43, MIDC, TTC Industrial Area, Turbhe, Off Thane Belapur Road, Navi Mumbai, District Thane - 400 703, India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Oxytocin

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    EPS
    Not Confirmed
    arrow

    Oxytocin

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    EPS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 26517

    Submission : 2012-09-22

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2008-029 - Rev 04

    Issue Date : 2023-11-03

    Type : Chemical

    Substance Number : 780

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2023-02-09

    Valid Till : 2026-02-08

    Written Confirmation Number : WC-0549

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 41701-002

    Start Marketing Date : 2011-03-18

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (5000000[iU]/5000000[iU])

    Marketing Category : BULK INGREDIENT

    KDMF VMF arrow-down
    ✖

    VMF Number : 5984

    Submission : 2010-07-22

    Status : Active

    Type : II

     Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Amiodarone Hydrochloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    EPS
    Not Confirmed
    arrow

    Amiodarone Hydrochloride

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    EPS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-09-21

    Pay. Date : 2013-09-10

    DMF Number : 21694

    Submission : 2008-06-12

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2009-291 - Rev 04

    Issue Date : 2025-05-14

    Type : Chemical

    Substance Number : 803

    Status : Valid

     JDMF EU-WCInactive-api
    ✖

    Date of Issue : 2022-06-29

    Valid Till : 2025-02-07

    Written Confirmation Number : WC-0123

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 65085-0022

    Start Marketing Date : 2018-12-31

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (25kg/25kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Aprepitant

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    EPS
    Not Confirmed
    arrow

    Aprepitant

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    EPS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 26065

    Submission : 2012-05-11

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2017-192 - Rev 03

    Issue Date : 2024-05-02

    Type : Chemical

    Substance Number : 2757

    Status : Valid

     JDMF EU-WCInactive-api
    ✖

    Date of Issue : 2022-06-29

    Valid Till : 2025-02-07

    Written Confirmation Number : WC-0123

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 65085-0043

    Start Marketing Date : 2018-11-21

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (20kg/20kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Baclofen

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    EPS
    Not Confirmed
    arrow

    Baclofen

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    EPS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2017-07-11

    Pay. Date : 2017-06-15

    DMF Number : 28455

    Submission : 2014-07-31

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2016-313 - Rev 01

    Issue Date : 2025-05-14

    Type : Chemical

    Substance Number : 653

    Status : Valid

     JDMF EU-WCInactive-api
    ✖

    Date of Issue : 2022-06-29

    Valid Till : 2025-02-07

    Written Confirmation Number : WC-0123

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 65085-0055

    Start Marketing Date : 2016-01-14

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (25kg/25kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Perindopril Erbumine

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    EPS
    Not Confirmed
    arrow

    Perindopril Erbumine

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    EPS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 28144

    Submission : 2014-03-29

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R0-CEP 2014-112 - Rev 03

    Issue Date : 2020-11-20

    Type : Chemical

    Substance Number : 2019

    Status : Valid

     JDMF EU-WCInactive-api
    ✖

    Date of Issue : 2022-06-29

    Valid Till : 2025-02-07

    Written Confirmation Number : WC-0123

    Address of the Firm :

    NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Trazodone Hydrochloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    EPS
    Not Confirmed
    arrow

    Trazodone Hydrochloride

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    EPS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2014-02-12

    Pay. Date : 2012-12-24

    DMF Number : 20920

    Submission : 2007-10-04

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2022-166 - Rev 02

    Issue Date : 2025-01-29

    Type : Chemical

    Substance Number : 2857

    Status : Valid

     JDMF EU-WCInactive-api
    ✖

    Date of Issue : 2022-06-29

    Valid Till : 2025-02-07

    Written Confirmation Number : WC-0123

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 65085-0014

    Start Marketing Date : 1999-06-29

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (25kg/25kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Services

    Upload your portfolio for free, ask us

    Packaging

    Click here to discover the service providers for Packaging

    Analytical

    Click here to discover the service providers for Analytical

    API Manufacturing

    Click here to discover the service providers for API Manufacturing

    Drug Product Manufacturing

    Click here to discover the service providers for Drug Product Manufacturing

    API & Drug Product Development

    Click here to discover the service providers for API & Drug Product Development

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Piramal Pharma Solutions and get a quotation

    Piramal Pharma Solutions is a supplier offers 123 products (APIs, Excipients or Intermediates).

    Find a price of Diltiazem Hydrochloride bulk with DMF, CEP, JDMF offered by Piramal Pharma Solutions

    Find a price of Ketoconazole bulk with DMF, CEP, JDMF offered by Piramal Pharma Solutions

    Find a price of Desmopressin Acetate bulk with DMF, CEP, WC offered by Piramal Pharma Solutions

    Find a price of Leuprolide Acetate bulk with DMF, CEP, WC offered by Piramal Pharma Solutions

    Find a price of Oxytocin bulk with DMF, CEP, WC offered by Piramal Pharma Solutions

    Find a price of Amiodarone Hydrochloride bulk with DMF, CEP offered by Piramal Pharma Solutions

    Find a price of Aprepitant bulk with DMF, CEP offered by Piramal Pharma Solutions

    Find a price of Baclofen bulk with DMF, CEP offered by Piramal Pharma Solutions

    Find a price of Bisoprolol Fumarate bulk with DMF, CEP offered by Piramal Pharma Solutions

    Find a price of Entacapone bulk with DMF, CEP offered by Piramal Pharma Solutions

    Find a price of Fosaprepitant bulk with DMF, JDMF offered by Piramal Pharma Solutions

    Find a price of Perindopril Erbumine bulk with DMF, CEP offered by Piramal Pharma Solutions

    Find a price of Pramipexole Dihydrochloride bulk with DMF, CEP offered by Piramal Pharma Solutions

    Find a price of Trazodone Hydrochloride bulk with DMF, CEP offered by Piramal Pharma Solutions

    Find a price of Verapamil Hydrochloride bulk with DMF, CEP offered by Piramal Pharma Solutions

    Find a price of Buserelin Acetate bulk with CEP, WC offered by Piramal Pharma Solutions

    Find a price of Calcitonin bulk with CEP, WC offered by Piramal Pharma Solutions

    Find a price of Cetrorelix Acetate bulk with DMF, WC offered by Piramal Pharma Solutions

    Find a price of Misoprostol bulk with DMF, CEP offered by Piramal Pharma Solutions

    Find a price of Oxytocin bulk with DMF, WC offered by Piramal Pharma Solutions

    Find a price of Somatostatin bulk with CEP, WC offered by Piramal Pharma Solutions

    Find a price of Terlipressin Acetate bulk with CEP, WC offered by Piramal Pharma Solutions

    Find a price of Acyclovir bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Armodafinil bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Brimonidine Tartrate bulk with CEP offered by Piramal Pharma Solutions

    Find a price of Cinacalcet Hydrochloride bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Clobazam bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Dabigatran Etexilate Mesylate bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Dapagliflozin Propanediol Monohydrate bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Donepezil bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Droxidopa bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Empagliflozin bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Flecainide bulk with CEP offered by Piramal Pharma Solutions

    Find a price of Levobunolol bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Lurasidone Hydrochloride bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Mebeverine bulk with CEP offered by Piramal Pharma Solutions

    Find a price of Mirabegron bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Octreotide Acetate bulk with WC offered by Piramal Pharma Solutions

    Find a price of Oxybutynin Hydrochloride bulk with CEP offered by Piramal Pharma Solutions

    Find a price of Paliperidone Palmitate bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Rivaroxaban bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Sulindac bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Tetrabenazine bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Tramadol Hydrochloride bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Valacyclovir Hydrochloride bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Varenicline Tartrate bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Vortioxetine Hydrobromide bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Anagrelide Hydrochloride bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Arginine Vasopressin bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Azilsartan bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Carbetocin Acetate bulk with WC offered by Piramal Pharma Solutions

    Find a price of Cloprostenol Sodium bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Deferasirox bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Dexlansoprazole bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Diltiazem Hydrochloride bulk with CEP offered by Piramal Pharma Solutions

    Find a price of Dronedarone Hydrochloride bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Gemfibrozil bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Gonadorelin Acetate bulk with WC offered by Piramal Pharma Solutions

    Find a price of Ibuprofen bulk with CEP offered by Piramal Pharma Solutions

    Find a price of Irbesartan bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Levoketoconazole bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Metaxalone bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Octreotide Acetate bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Oxytocin bulk with WC offered by Piramal Pharma Solutions

    Find a price of Pregabalin bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Quetiapine Hemifumarate bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Tetracosactide bulk with WC offered by Piramal Pharma Solutions

    Find a price of Verapamil Hydrochloride bulk with CEP offered by Piramal Pharma Solutions

    Find a price of EDOXABAN TOSYLATE MONOHYDRATE bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Abacavir Sulfate bulk offered by Piramal Pharma Solutions

    Find a price of Aprepitant bulk offered by Piramal Pharma Solutions

    Find a price of Bexagliflozin bulk offered by Piramal Pharma Solutions

    Find a price of Halothane bulk offered by Piramal Pharma Solutions

    Find a price of Isoflurane bulk offered by Piramal Pharma Solutions

    Find a price of Paroxetine Hydrochloride bulk offered by Piramal Pharma Solutions

    Find a price of Pramipexole Dihydrochloride bulk offered by Piramal Pharma Solutions

    Find a price of Promethazine Teoclate bulk offered by Piramal Pharma Solutions

    Find a price of Rimegepant Sulfate bulk offered by Piramal Pharma Solutions

    Find a price of Spironolactone bulk offered by Piramal Pharma Solutions

    Find a price of Tafenoquine Succinate bulk offered by Piramal Pharma Solutions

    Find a price of Tolcapone bulk offered by Piramal Pharma Solutions

    Find a price of Trazodone Hydrochloride bulk offered by Piramal Pharma Solutions

    Find a price of Abaloparatide Acetate bulk offered by Piramal Pharma Solutions

    Find a price of Apixaban bulk offered by Piramal Pharma Solutions

    Find a price of Apremilast bulk offered by Piramal Pharma Solutions

    Find a price of Arginine Vasopressin bulk offered by Piramal Pharma Solutions

    Find a price of Atosiban bulk offered by Piramal Pharma Solutions

    Find a price of Cabozantinib bulk offered by Piramal Pharma Solutions

    Find a price of Camylofin Dihydrochloride bulk offered by Piramal Pharma Solutions

    Find a price of Canagliflozin bulk offered by Piramal Pharma Solutions

    Find a price of Carmustine bulk offered by Piramal Pharma Solutions

    Find a price of Cetrorelix Acetate bulk offered by Piramal Pharma Solutions

    Find a price of Corticotropin bulk offered by Piramal Pharma Solutions

    Find a price of Degarelix Acetate bulk offered by Piramal Pharma Solutions

    Find a price of Desmopressin Acetate bulk offered by Piramal Pharma Solutions

    Find a price of Desvenlafaxine Succinate bulk offered by Piramal Pharma Solutions

    Find a price of Edoxaban Tosylate bulk offered by Piramal Pharma Solutions

    Find a price of Eluxadoline bulk offered by Piramal Pharma Solutions

    Find a price of Glatiramer Acetate bulk offered by Piramal Pharma Solutions

    Find a price of Glucagon bulk offered by Piramal Pharma Solutions

    Find a price of Goserelin Acetate bulk offered by Piramal Pharma Solutions

    Find a price of Lanreotide Acetate bulk offered by Piramal Pharma Solutions

    Find a price of Lercanidipine bulk offered by Piramal Pharma Solutions

    Find a price of Leuprolide Acetate bulk offered by Piramal Pharma Solutions

    Find a price of Linaclotide bulk offered by Piramal Pharma Solutions

    Find a price of Linagliptin bulk offered by Piramal Pharma Solutions

    Find a price of Liraglutide bulk offered by Piramal Pharma Solutions

    Find a price of Mecamylamine Hydrochloride bulk offered by Piramal Pharma Solutions

    Find a price of Oxytocin bulk offered by Piramal Pharma Solutions

    Find a price of Paliperidone bulk offered by Piramal Pharma Solutions

    Find a price of Plecanatide bulk offered by Piramal Pharma Solutions

    Find a price of Semaglutide bulk offered by Piramal Pharma Solutions

    Find a price of Succimer bulk offered by Piramal Pharma Solutions

    Find a price of Sugammadex Sodium bulk offered by Piramal Pharma Solutions

    Find a price of Sulfiram bulk offered by Piramal Pharma Solutions

    Find a price of Tafenoquine bulk offered by Piramal Pharma Solutions

    Find a price of Teduglutide bulk offered by Piramal Pharma Solutions

    Find a price of Terlipressin Acetate bulk offered by Piramal Pharma Solutions

    Find a price of Trientine Hydrochloride bulk offered by Piramal Pharma Solutions

    Find a price of Triptorelin Acetate bulk offered by Piramal Pharma Solutions

    Find a price of Valacyclovir bulk offered by Piramal Pharma Solutions

    Find a price of Vibegron bulk offered by Piramal Pharma Solutions

    Find a price of RABACFOSADINE SUCCINATE bulk offered by Piramal Pharma Solutions

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search